Literature DB >> 16749857

High-speed screening and QSAR analysis of human ATP-binding cassette transporter ABCB11 (bile salt export pump) to predict drug-induced intrahepatic cholestasis.

Hiroyuki Hirano1, Atsuo Kurata, Yuko Onishi, Aki Sakurai, Hikaru Saito, Hiroshi Nakagawa, Makoto Nagakura, Shigeki Tarui, Yoichi Kanamori, Masato Kitajima, Toshihisa Ishikawa.   

Abstract

Human ATP-binding cassette transporter ABCB11 (SPGP/BSEP) mediates the elimination of bile salts from liver cells and thereby plays a critical role in the generation of bile flow. In the present study, we have developed in vitro high-speed screening and quantitative structure-activity relationship (QSAR) analysis methods to investigate the interaction of ABCB11 with a variety of drugs. Plasma membrane vesicles prepared from insect cells overexpressing human ABCB11 were used to measure the ATP-dependent transport of [14C]taurocholate. Over 40 different drugs and natural compounds were tested to evaluate their interaction with ABCB11-mediated taurocholate transport. On the basis of the extent of inhibition, we have analyzed the QSAR to identify one set of chemical fragmentation codes closely associated with the inhibition of ABCB11. This approach can be used to predict compounds with a potential risk of drug-induced intrahepatic cholestasis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16749857     DOI: 10.1021/mp060004w

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  9 in total

Review 1.  An updated review on drug-induced cholestasis: mechanisms and investigation of physicochemical properties and pharmacokinetic parameters.

Authors:  Kyunghee Yang; Kathleen Köck; Alexander Sedykh; Alexander Tropsha; Kim L R Brouwer
Journal:  J Pharm Sci       Date:  2013-05-07       Impact factor: 3.534

2.  Principles and Experimental Considerations for In Vitro Transporter Interaction Assays.

Authors:  Sid Bhoopathy; Chris Bode; Vatsala Naageshwaran; Erica Weiskircher-Hildebrandt; Venkata Mukkavilli; Ismael J Hidalgo
Journal:  Methods Mol Biol       Date:  2021

Review 3.  Molecular Modeling of Drug-Transporter Interactions-An International Transporter Consortium Perspective.

Authors:  Avner Schlessinger; Matthew A Welch; Herman van Vlijmen; Ken Korzekwa; Peter W Swaan; Pär Matsson
Journal:  Clin Pharmacol Ther       Date:  2018-08-30       Impact factor: 6.875

4.  Use of cassette dosing in sandwich-cultured rat and human hepatocytes to identify drugs that inhibit bile acid transport.

Authors:  Kristina K Wolf; Sapana Vora; Lindsey O Webster; Grant T Generaux; Joseph W Polli; Kim L R Brouwer
Journal:  Toxicol In Vitro       Date:  2009-08-23       Impact factor: 3.500

Review 5.  Technical pitfalls and improvements for high-speed screening and QSAR analysis to predict inhibitors of the human bile salt export pump (ABCB11/BSEP).

Authors:  Hikaru Saito; Masako Osumi; Hiroyuki Hirano; Wangsoo Shin; Ryota Nakamura; Toshihisa Ishikawa
Journal:  AAPS J       Date:  2009-08-18       Impact factor: 4.009

Review 6.  Adverse Outcome Pathways and Drug-Induced Liver Injury Testing.

Authors:  Mathieu Vinken
Journal:  Chem Res Toxicol       Date:  2015-07-02       Impact factor: 3.739

Review 7.  Can Bile Salt Export Pump Inhibition Testing in Drug Discovery and Development Reduce Liver Injury Risk? An International Transporter Consortium Perspective.

Authors:  J Gerry Kenna; Kunal S Taskar; Christina Battista; David L Bourdet; Kim L R Brouwer; Kenneth R Brouwer; David Dai; Christoph Funk; Michael J Hafey; Yurong Lai; Jonathan Maher; Y Anne Pak; Jenny M Pedersen; Joseph W Polli; A David Rodrigues; Paul B Watkins; Kyunghee Yang; Robert W Yucha
Journal:  Clin Pharmacol Ther       Date:  2018-11       Impact factor: 6.875

8.  Using Jupyter Notebooks for re-training machine learning models.

Authors:  Aljoša Smajić; Melanie Grandits; Gerhard F Ecker
Journal:  J Cheminform       Date:  2022-08-13       Impact factor: 8.489

9.  Adverse Outcome Pathways as Tools to Assess Drug-Induced Toxicity.

Authors:  Mathieu Vinken
Journal:  Methods Mol Biol       Date:  2016
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.